Research graph
References from Methods for a Community-Engaged Randomized Trial for Urgency Incontinence. Local targets link to admitted publications; unresolved targets remain external evidence.
Economic burden of urgency urinary incontinence in the United States: a systematic review
2014 · External reference
Urinary incontinence in women
10.1038/nrdp.2017.42 · 2017 · External reference
An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction
10.1007/s00192-009-0976-9 · 2010 · External reference
Systematic review and meta-analysis of urinary incontinence prevalence and population estimates
10.1002/nau.25276 · 2024 · External reference
Urgency, urge incontinence and voiding symptoms in men and women aged 70 years and over
10.1046/j.1464-4096.2001.01684.x · 2002 · External reference
Prevalence and factors related to urinary incontinence in older adults women worldwide: a comprehensive systematic review and meta-analysis of observational studies
10.1186/s12877-021-02135-8 · 2021 · External reference
Epidemiological trends and future care needs for pelvic floor disorders
10.1097/gco.0000000000000200 · 2015 · External reference
Comparison of different types of therapy for overactive bladder: a systematic review and network meta-analysis
10.3389/fmed.2022.1014291 · 2022 · External reference
What are the short-term benefits and potential harms of therapeutic modalities for the management of overactive bladder syndrome in women? A review of evidence under the auspices of the European Association of Urology, Female Non-neurogenic Lower Urinary Tract Symptoms Guidelines Panel
10.1016/j.eururo.2023.05.014 · 2023 · External reference
Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q
10.1023/a:1016370925601 · 2002 · External reference
Development and validation of the functional assessment of chronic illness therapy treatment satisfaction (FACIT TS) measures
10.1007/s11136-013-0520-8 · 2014 · External reference
The Pelvic Organ Prolapse Incontinence Sexual Questionnaire, IUGA-revised (PISQ-IR)
10.1007/s00192-012-1952-3 · 2013 · External reference
Community Engagement Methods for a Urgency Urinary Incontinence Trial
External reference
Content validation of the patient-reported outcomes measurement information system (PROMIS) framework in women with urinary incontinence
10.1002/nau.21048 · 2011 · External reference
Psychometric validation of the overactive bladder satisfaction with treatment questionnaire (OAB-SAT-q)
10.1002/nau.20672 · 2009 · External reference
Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension
10.1001/jama.2022.21022 · 2022 · External reference
The responsiveness of the Overactive Bladder Questionnaire (OAB-q)
10.1007/s11136-004-0706-1 · 2005 · External reference
Determining the importance of change in the Overactive Bladder Questionnaire
10.1016/j.juro.2006.03.088 · 2006 · External reference
Minimum important difference for validated instruments in women with urge incontinence
10.1002/nau.21028 · 2011 · External reference
A multicenter prospective study for overactive bladder patient treatment satisfaction with mirabegron after being unsatisfied with antimuscarinic therapy (FAVOR study)
10.1002/nau.24505 · 2020 · External reference
Factors associated with improvements in patient-reported outcomes during mirabegron or antimuscarinic treatment of overactive bladder syndrome: a registry study (PERSPECTIVE)
10.1007/s12325-019-00994-7 · 2019 · External reference
Mirabegron improves quality-of-life, treatment satisfaction, and persistence in patients with overactive bladder: a multi-center, non-interventional, real-world, 12-month study
10.1080/03007995.2017.1419170 · 2018 · External reference
Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER)
10.1186/s12955-018-0892-0 · 2018 · External reference
Pelvic Floor Disorders Network. Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence
10.1056/nejmoa1208872 · 2012 · External reference
OnabotulinumtoxinA vs sacral neuromodulation on refractory urgency urinary incontinence in women: a randomized clinical trial
10.1001/jama.2016.14617 · 2016 · External reference
Sample sizes based on the log-rank statistic in complex clinical trials
10.2307/2531910 · 1988 · External reference
Designing complex group sequential survival trials
10.1002/sim.1193 · 2002 · External reference
